Skip to Content

View Additional Section Content

A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy (ESCAPE-NA-1 Trial)

Clinical Trial Categories

  • Stroke Research
Contact
Patricia Bussinger, CRNP at 215-481-5373

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM